HS has been continuously researched since the 1800’s.•More than 5,000 research publications have been dedicated to Hidradenitis Suppurativa. •HS research publications reached a staggering 1,157 between 2023 and 2024. That's a lot of funding and effort.
Research includes genes, genetics, bacteria, comorbidities, integrative medicine, nutrition, and so MUCH more.
HS has 47 current clinical trials, including both drug and nondrug options.
There are currently 2 treatments that have been FDA approved, with another one expected to be approved by the end of 2024 or early 2025. "BIMZELX® (bimekizumab) a possible THIRD FDA approved treatment option on the way"
Research and study on HS have been and will continue to be conducted. Progress is being made rapidly on advancements.
We're not being ignored, and neither is our illness. There is hope!
Special Note: Researched, compiled, and written by Denise Fixsen. This information is backed by my 46 years of living with Hidradenitis Suppurativa, 10 years of dealing with multiple chronic illnesses, 36 years of advocacy, and continuous education. And to ensure accuracy, reliability, and trustworthiness, I incorporate peer-reviewed studies and other high-quality sources into my articles and material. I also wanted to inform you that I’ve chosen to end my collaboration with editors on my articles. Although there may be grammar errors due to brain illnesses (mostly), with this said, my content remains reliable, factual, and solid.
Medical Disclaimer: This content is solely for information, education, and support. The purpose is not to serve as a replacement for professional medical advice, diagnosis, or treatments.
Sources: National Institutes of Health,Velpeau A. Dictionnaire de Medicine, un Repertoire des Sciences Medicales sons le Rapport, Theorique et Pratique. 2nd ed Paris. 1839. 91.
FAQ posted on 09-13-2024